Stay abreast of the latest scientific developments and learn how the biopharma industry and medical community are finding new ways to improve decision-making and patient care. Here, we share our perspectives on a variety of topics in biopharma, healthcare, medical communications, and more.
Vaniam Group and oncology experts discuss the hottest topics from oncology and hematology conferences.
Ms. Scholz brings 25 years of leadership experience driving the success of oncology brands across several top pharmaceutical companies
Early-career clinical investigators continue year-long mentorship and professional development program led by international thought leaders
Awards presented at the 5th Annual LEAD conference for women in oncology and hematology
Mr. Neave brings 15+ years of CFO experience within mid- to large-sized medical communications and pharma services agencies
This marks the fourth consecutive year that Vaniam Group has qualified for this prestigious honor.
Patricia Mae Garcia Santos, MD, MS, receives annual Conquer Cancer-Women Leaders in Oncology “Women Who Conquer Cancer” Young Investigator Award and Tafadzwa L. Chaunzwa, MD, MHS, receives annual Conquer Cancer-Vaniam Group LLC Young Investigator Award, dedicated to Black, African, or African American cancer researchers
With 3 decades as a leading gynecologic oncologist, Dr. Coleman’s appointment reinforces Vaniam Group’s commitment to scientific excellence and advancing patient care.
Nineteen early-career clinical investigators to receive year-long mentorship and professional development program led by international thought leaders.
Ms. Franson will help biopharma clients design a phased approach to inform and execute clinical development plans, amplify awareness within clinician and patient communities, and form partnerships necessary to accelerate clinical trial completion.
After 8 years in leadership roles at Vaniam Group, Herzog’s appointment demonstrates agency’s continued focus on client service, operational excellence, and healthy growth.
Dr Nze Is Second Annual Recipient of Grant Dedicated to Black, African, or African American Cancer Researchers; Will Research Barriers to Minority Participation in Lymphoma Clinical Trials.
Based on 2022 employee survey data, Vaniam Group scored among top 20 US health companies.
Vaniam Group Receives Recognition for Second Consecutive Year.
Vaniam Group Funds Annual Award Given to Black, African, or African American Cancer Researchers.
Vaniam Group to Match $100,000 for Young Investigator Award Endowment to Accelerate Future Oncology Research.
